AGUETTANT est membre de Lyonbiopôle

General information

1 rue Alexander Fleming

69007 LYON

Incorporated in: 1835/01/01

Number of employees: 500

Turnover: €110M (in 2015)

More information


Main activity

For more than a century, Aguettant has developped, manufactured and marketed essential drugs for hospitals. Our specialty areas are: - anaesthesia, intensive care and emergency medicine; - essential micronutrients for injection, used in parenteral nutrition; - the treatment of movement disorders due to Parkinson's disease; - infusion and rinsing solutions. With sales around €100 M and 500 employees, the Aguettant Group develops several unique know-hows: - ready-to-use pre-filled syringes, ideal for emergency medicine and hospital settings;  - pen for self-injection at home; - trace elements in injectable solutions; - through PX'Therapeutics, a subsidiary of the Aguettant Group, the development and production of therapeutic proteins (including monoclonal antibodies).

Products / Services / Technologies
Partnership opportunities / Licensing

Strategic area of application
Human Medicine

Application market
Neurological diseases - Others

Therapeutics, Pharma or Biotech - Medical device

Drug delivery device - services